• Physical Sciences & Engineering

  • Events 

    Tuesday, October 25, 2016 | 9:00 AM - 5:00 PM

    Emerging Paradigms in Drug Discovery & Chemical Biology

    Speakers: Marcus Bantscheff (Cellzome/GSK), Benjamin F Cravatt (The Scripps Research Institute), Craig Crews (Yale University), Howard Hang (The Rockefeller University), Ruth Nussinov (National Cancer Institute), Brian Raymer (Pfizer), Bryan Roth (University of North Carolina), Eranthie Weerapana (Boston College)

    Chemical Biology is changing the face of drug discovery. This symposium will highlight recent developments in the field, featuring examples from neurobiology and cancer, the ubiquitin proteasome system, GPCRs, and protein lipidation.

    Wednesday, November 9, 2016 | 8:30 AM - 5:15 PM

    Equivalence of Complex Drug Products: Scientific and Regulatory Challenges

    Keynote Speaker: Lawrence D. Mayer (Jazz Pharmaceuticals)

    Explore approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and compare biological and non-biological complex drug families.

    Friday, March 3, 2017 | 9:00 AM - 6:30 PM

    11th Annual Machine Learning Symposium

    The 11th Annual Machine Learning Symposium is the latest in a highly successful series bringing together leading researchers from academia and industry to present new algorithms for statistical learning and novel theoretical approaches and discuss applications of ML to real-world data. In addition, the workshop will address limitations of existing techniques and solutions to overcome such shortcomings.

  • Past Events

    September 21 - 23, 2016

    13th Key Symposium 2016: Bioelectronic Medicine — Technology Targeting Molecular Mechanisms

    Featuring: Peder S. Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.

    Friday, September 16, 2016 | 8:30 AM - 6:00 PM

    Big Data, Consumer Technology, and the Obesity Epidemic: Emerging Science and Ethical Considerations

    Speakers: Lori B. Andrews (Chicago-Kent College of Law, Illinois Institute of Technology), Gary Bennett (Duke University), Barbara E. Millen (Millennium Prevention, Inc.), Tooraj Mirshahi (Geisinger Clinic), Satchidananda Panda (SALK Institute), Ruth E. Patterson (University of California San Diego), Michael K. Price (Georgia State University), Karandeep Singh (University of Michigan), and Nicholas Tatonetti (Columbia University)

    Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?

    Friday, September 9, 2016 | 12:00 PM - 4:00 PM

    Protein Engineering and Protein Therapeutics

    Speakers: Yael David (MSKCC), Shohei Koide (NYU Langone Medical Center), Alexander J. Kasznel (University of Pennsylvania), Jonathan R. Lai (Albert Einstein College of Medicine), Jim Wells (University of California San Francisco), and Manoj Charati (Pfizer)

    This symposium will highlight state-of-the-art technologies in protein and antibody engineering, and antibody-drug conjugates. The implementation of these methods to specific diseases, and unique research tools, will also be discussed.

    Wednesday, July 13, 2016 | 9:00 AM - 5:00 PM

    MicroRNAs: A Gene Silencing Mechanism with Therapeutic Implications

    Keynote Speaker: David Bartel (Whitehead/MIT/HHMI)
    Speakers: Paul Grint (Regulus Therapeutics), David S Hong (The University of Texas MD Anderson Cancer Center ), Daniel J Siegwart (University of Texas Southwestern Medical Center), Frank Slack (BIDMC Cancer Center/Harvard Medical School), James W Welsh (The University of Texas MD Anderson Cancer Center)

    miRNAs play critical roles in regulating gene expression. This symposium will present up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.

  • Publications 


    The Physics of Everything

    Is there a limit to human knowledge? Where do philosophy and physics intersect? Are we alone in the universe? Answering these and other questions, this six-part series united some of our most vibrant public intellectuals and communicators for explorations that reflect on the current state of modern physical sciences, its greatest mysteries and future endeavors, and its philosophical significance for our understanding of reality and the spiritual dimension of human existence.


    Special Issue: Countermeasures Against Chemical Threats II

    Edited by Jeffrey D. Laskin (Rutgers University School of Public Health)

    Discussions of various countermeasures to chemical threats.


    Special Issue: Countermeasures Against Chemical Threats I

    Edited by Jeffrey D. Laskin (Rutgers University School of Public Health)

    Chemical threats, both accidental and deliberate, are of critical concern globally. This, the first of two Annals issues devoted to this topic, presents 23 papers that discuss various countermeasures against chemical threats.

    Volume 1374


    Mobile Health: The Power of Wearables, Sensors, and Apps to Transform Clinical Trials

    Organizers: Glen de Vries (Medidata Solutions), John J. Mastrototaro (Medtronic), Bernard Munos (FasterCures), Fiorenzo Omenetto (Tufts University), Leonard Sacks (U.S. Food and Drug Administration), Melanie Brickman Stynes (The New York Academy of Sciences), Brooke Grindlinger (The New York Academy of Sciences), and Daniel Radiloff (The New York Academy of Sciences)

    This eBriefing considers the use of data from wearable sensors and mobile devices in medical care and clinical trials and looks at security and regulatory issues for health data.